SCHEMBL7182489

SCHEMBL7182489

CCOc1c(C=CC(=O)c2ccc(N)cc2)cc(C(C)(C)C)c(O)c1C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.45
CTSB P07858 1/20 0.45
TNFRSF1A P19438 1/20 0.43
PTPN1 P18031 1/20 0.43
MAOB P27338 5/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
CYP1B1 Q16678 4/20 0.42
CYP1A1 P04798 3/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
KRAS P01116 1/20 0.41
MAOA P21397 1/20 0.40
DPP4 P27487 2/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182485 1.00 CTSL (0.45) CTSLCTSBTNFRSF1APTPN1MAOB
SCHEMBL7185464 0.92 ABCG2 (0.44) CTSLCTSBTNFRSF1APTPN1ABCG2
SCHEMBL7185461 0.92 ABCG2 (0.44) CTSLCTSBTNFRSF1APTPN1ABCG2
SCHEMBL7191637 0.91 ABCG2 (0.52) CTSLCTSBTNFRSF1APTPN1MAOB
SCHEMBL7191633 0.91 ABCG2 (0.52) CTSLCTSBTNFRSF1APTPN1MAOB
SCHEMBL7186190 0.88 CTSL (0.53) CTSLCTSBTNFRSF1APTPN1ABCG2
SCHEMBL7186193 0.88 CTSL (0.53) CTSLCTSBTNFRSF1APTPN1ABCG2
SCHEMBL7187650 0.88 CTSL (0.43) CTSLCTSBPTPN1MAOBABCG2
SCHEMBL7186260 0.88 TNFRSF1A (0.41) TNFRSF1APTPN1MAOBABCG2CYP1B1
SCHEMBL7186257 0.88 TNFRSF1A (0.41) TNFRSF1APTPN1MAOBABCG2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed